Evaluation of Comfort of Ocular Lubricants in Symptomatic Contact Lens Wearers

October 10, 2023 updated by: Alcon Research
The purpose of this study is to evaluate the ocular comfort of 3 ocular lubricants and a comparator.

Study Overview

Status

Completed

Conditions

Detailed Description

The expected duration of subject participation is at least 7 days. This study will be conducted in Australia and Canada.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New South Wales
      • Sydney, New South Wales, Australia, 2052
        • School of Optometry and Vision
    • Victoria
      • Waurn Ponds, Victoria, Australia, 3216
        • Deakin Collaborative Eye Care Clinic, Deakin University
    • Ontario
      • Waterloo, Ontario, Canada, N2L3G1
        • School of Optometry and Vision Science, University of Waterloo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Key Inclusion Criteria:

  • Is able to understand and sign an approved information consent letter;
  • Habitually wears daily disposable soft contact lenses in both eyes
  • Uses rewetting drops on a regular basis;
  • Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

  • Routinely sleeps in habitual contact lenses;
  • Has any known active ocular disease and/or infection;
  • Is pregnant or lactating;
  • Other protocol specified exclusion criteria may apply.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: OTF Test 1
One application of ocular lubricant to each eye at night for 5 consecutive nights
Ocular lubricant in 1 of 3 test formulations
Experimental: OTF Test 2
One application of ocular lubricant to each eye at night for 5 consecutive nights
Ocular lubricant in 1 of 3 test formulations
Experimental: OTF Test 3
One application of ocular lubricant to each eye at night for 5 consecutive nights
Ocular lubricant in 1 of 3 test formulations
Active Comparator: Ocular lubricant
One drop of ocular lubricant applied to each eye at night for 5 consecutive nights
Commercially available ocular lubricant
Other Names:
  • SYSTANE™ Gel
  • Genteal™ Gel

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ocular comfort
Time Frame: Up to Day 5
Comfort will be rated using a visual analog scale (0-100) from 0-100, where 0=poor and 100=excellent.
Up to Day 5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Clinical Trial Lead, Dry Eye, Alcon Research, LLC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

October 2, 2023

Study Completion (Actual)

October 2, 2023

Study Registration Dates

First Submitted

February 14, 2023

First Submitted That Met QC Criteria

February 14, 2023

First Posted (Actual)

February 23, 2023

Study Record Updates

Last Update Posted (Actual)

October 11, 2023

Last Update Submitted That Met QC Criteria

October 10, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • DEJ475-E006

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dry Eye

Clinical Trials on OTF Ocular Lubricant

3
Subscribe